Andere talen Boditech Med Inc.

Aandelen

A206640

KR7206640005

slotkoers Korea S.E. Andere beurzen 00:00:00 23-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
16.590 ^KRW	-2,41%		-3,55%	-19,07%

2023	Boditech Med Inc. en SphingoTec GmbH gaan een marktontwikkelingsovereenkomst aan om de commercialisering van de nierfunctie biomarker PenKid te stimuleren	CI
2022	Boditech Med Inc. en SphingoTec GmbH sluiten niet-exclusieve licentieovereenkomst met royalty's	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.	21/02
Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid	31-08-23
MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH'S AFIAS-10 SYSTEM	20-04-23
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	28-03-23
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	28-03-23
Boditech Med Inc.'s Equity Buyback announced on September 29, 2022, has expired with 496,620 shares, representing 2.21% for KRW 4,994.56 million	28-03-23
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	29-12-22
Boditech Med Inc. and SphingoTec GmbH Enters into Non-Exclusive Royalty-Bearing License Agreement	15-11-22
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.	29-09-22
Boditech Med Inc. authorizes a Buyback Plan.	29-09-22
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.	13-06-22
Boditech Med Inc.'s Equity Buyback announced on December 14, 2021, has expired with 297,901 shares, representing 1.31% for KRW 4,987.06 million.	13-06-22
Novo Integrated Sciences, Boditech Med Sign Memorandum of Understanding for Distribution of Diagnostic Technologies	29-03-22
Novo Integrated Sciences, Inc. Signs Memorandum of Understanding with Boditech Med to Market and Distribute in North America	29-03-22
Boditech Med Announces the Formation of a U.S. Based Advisory Board and its First Member, Zachariah P. Zachariah, M.D	24-03-22
Boditech Med Partners with Novo Integrated Sciences, Inc. to Market and Distribute Lower-Cost, Rapid Testing in North America	22-03-22
Boditech Med to Expand to U.S., North America	18-03-22
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.	14-03-22
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.	04-03-22
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.	04-03-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Boditech Med Inc.

Aandelen

A206640

KR7206640005

Andere talen

Filters